Lupus Nephritis
Study: Positive Results from Trial of Benlysta for Treatment of Lupus Nephritis
GlaxoSmithKline (GSK) has recently completed and released the results of Phase 3 of its study of benlysta. This drug is made for the treatment
Rare Patient News. Well Done.
Positive Phase 2 Trial Results for Galactosemia Could Lead to Approval of New Therapy
- January 17, 2020
12 Healthcare Milestones that Defined the Decade
Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?
Huntington’s Disease Patients Place Hopes in Clinical Trial
LATEST PATIENT WORTHY ARTICLES
Rare Disease
In February, Rare Disease Week Will Take Over Capitol Hill. They Want You Come Tell Your Story.
Who is most affected when we talk about creating solutions for rare diseases? Those who live with them and their families. Patient communities know what
Rare Disease
Interview with Dr. Wang, an Advocate of Autoimmune Pulmonary Alveolar Proteinosis
Savara Pharmaceuticals has recently interviewed Dr. Tisha Wang, who is a pulmonologist and critical care physician at UCLA. Dr. Wang is also an advocate
-300x300.jpg)
Multiple Sclerosis
Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
According to recent articles in Runner’s World Magazine, having a diagnosis of multiple sclerosis has not stopped Cheryl Hile, Jennifer Lee or Melissa Ossanna. Each
Rare Disease
NSGC 2019 Conference Highlights Part 2
This is NSGC 2019 Conference Highlights Part 2, click here for part 1. An early morning session on the final day of the conference featured
Acute Myeloid Leukemia
Paul Pavao’s Blastic Plasmacytoid Dendritic Cell Neoplasm Story
Written by: Paul Pavao The most important thing I can tell you is that Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) can be survived. As of
